Taysha Gene Therapies Inc. (TSHA)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
3. 62
-0.11
-2.9491%
$
1.44B Market Cap
- P/E Ratio
- Div Yield
2.75M Volume
-0.41 Eps
$ 3.73
Previous Close 
Want to track TSHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taysha Gene Therapies Inc. (TSHA) Statistics
Valuation metrics
Market Cap 1.44B
Enterprise value 1.04B
Trailing P/E (ttm) -10.62
Forward P/E -
PEG ratio 0.64
Price/Sales (ttm) 261.84
Price/Book (mrq) 4.28
Enterprise Value/Revenue 188.94
Enterprise Value/EBITDA -6.96
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.38M
Average volume (90 days) 3.83M
Price summary
52-Week low 3.46
52-Week high 7.3
Beta -
50-Day moving average 4.87
200-Day moving average 5.64
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -27.28%
Operating margin -27.92%
Operational effectiveness
Return on assets -0.32%
Return on equity -0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.41
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.23
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 17.76%
Book value per share (mrq) 1.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
